Limited time75% off all plans
Get the app

Donor selection criteria

Donor selection criteria

Donor selection criteria

On this page

Donor Selection - The Gatekeepers' Rules

  • Core Principle: Maximize graft survival while minimizing disease transmission.

  • General Criteria: Hemodynamic stability, absence of irreversible organ damage.

  • Absolute Contraindications:

    • Uncontrolled systemic infection (sepsis).
    • Most extracranial malignancies.
    • HIV infection (though evolving with the HOPE Act).
    • Prion diseases (e.g., CJD).
  • Relative Contraindications:

    • Advanced age (> 70-80 years, varies by organ).
    • Hepatitis B/C (can donate to positive recipients).
    • Treated, localized cancers with long disease-free interval.
    • Significant comorbidities (severe HTN, DM).

⭐ Primary non-metastasizing brain tumors (e.g., low-grade astrocytoma) generally DO NOT preclude organ donation.

Organ-Specific Criteria - Matchmaking Organs

  • Heart & Lungs:

    • Primary: ABO compatibility & size matching (height, weight ±20%).
    • Heart: Panel Reactive Antibody (PRA) < 10%.
    • Lungs: Lung Allocation Score (LAS) guides priority based on urgency/benefit. Donor must have clear chest imaging and no aspiration.
  • Liver:

    • Primary: ABO compatibility & size.
    • Priority set by MELD/PELD score.
    • Absence of extrahepatic malignancy or uncontrolled sepsis.
  • Kidney:

    • Primary: ABO compatibility & Human Leukocyte Antigen (HLA) matching.
    • Negative complement-dependent cytotoxicity (CDC) crossmatch is mandatory.
    • PRA screens for pre-formed anti-HLA antibodies.

⭐ For kidneys, HLA-DR matching is the most critical for long-term graft survival, followed by HLA-B and then HLA-A.

Infection Screening - Dodging Dangerous Donations

  • Core Serologies: Mandatory screening for all potential donors.
    • HIV-1/2 (Antibody & NAT)
    • Hepatitis B (HBsAg, anti-HBc, NAT)
    • Hepatitis C (Anti-HCV, NAT)
    • Syphilis (e.g., RPR)
  • Viral Panel:
    • CMV (IgG) - critical for matching
    • EBV (VCA IgG)
    • HTLV-1/2
  • Targeted Screening: Based on exposure/geography.
    • West Nile Virus (NAT)
    • Trypanosoma cruzi (Chagas disease)
    • SARS-CoV-2

⭐ Nucleic Acid Testing (NAT) is vital for detecting recent infections (HIV, HBV, HCV) during the serological "window period," especially in donors with high-risk behaviors.

Special Cases - Expanded Criteria Donors

  • Donors aged > 60 years, or aged > 50 years with at least two of the following:
    • History of hypertension (HTN)
    • Terminal creatinine > 1.5 mg/dL
    • Death from cerebrovascular accident (CVA)
  • ECD organs carry a higher risk of graft dysfunction and failure but expand the donor pool, offering a survival benefit over waiting.

⭐ Despite increased risks, accepting an ECD kidney provides a significant mortality benefit compared to remaining on the transplant waitlist, especially for older recipients.

High‑Yield Points - ⚡ Biggest Takeaways

  • ABO compatibility is the most critical initial step in donor selection, a non-negotiable prerequisite.
  • HLA matching, particularly for HLA-A, B, and DR loci, is crucial for long-term graft survival, especially in kidney and bone marrow transplants.
  • Absolute contraindications include active infections (HIV, viral hepatitis), uncontrolled sepsis, and most malignancies.
  • Donor age is a significant factor; organs from very young or elderly donors may have reduced function.
  • Hemodynamic stability and adequate end-organ function are essential for deceased donors.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS
Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Everything you need for USMLE prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE